EIR GlaxoSmithKline Biologicals SA Jun 2008

Jacqueline Diaz Albert FDA, Paula Trost FDA$595.00 - Available Now

FDA investigators audited the GlaxoSmithKline Biologicals SA - Rixensart, Belgium facility and issued inspectional observation (via FDA 483) on 25 Jun 2008.

Product details

  • Category:
  • Inspection end: 25 Jun 2008
  • Location: Rixensart, Belgium
  • FEI: 3002875226
Add To Cart